A Study of Intravenous RO6895882 and MPDL3280A Combination in Patients With Locally Advanced and/or Metastatic Solid Tumors

Clinical Trial ID NCT02350673

PubWeight™ 2.32‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02350673

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins. Front Immunol 2016 0.80
2 Emerging therapeutic targets in metastatic progression: A focus on breast cancer. Pharmacol Ther 2016 0.79
3 Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. J Immunol Res 2015 0.78
Next 100